10x Genomics, Inc. (TXG) › Shareholders' Equity10x Genomics, Inc. (TXG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$96.43M2017: -$112.51M2018: -$219.99M2019: $420.08M2020: $739.07M2021: $817.57M2022: $805.74M2023: $741.04M2024: $710.13M2025: $796.33M$796.33M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$796.33M+12.1%2024$710.13M-4.2%2023$741.04M-8.0%2022$805.74M-1.4%2021$817.57M+10.6%2020$739.07M+75.9%2019$420.08M+291.0%2018-$219.99M-95.5%2017-$112.51M-16.7%2016-$96.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share